8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001213900-20-009857
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading ea120937-8k_elitepharma.htm…